nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—Spironolactone—dilated cardiomyopathy	0.341	1	CrCtD
Progesterone—NR3C2—dilated cardiomyopathy	0.171	1	CbGaD
Progesterone—NR3C2—Spironolactone—dilated cardiomyopathy	0.0588	0.295	CbGbCtD
Progesterone—PGR—Spironolactone—dilated cardiomyopathy	0.038	0.19	CbGbCtD
Progesterone—SHBG—Spironolactone—dilated cardiomyopathy	0.0364	0.183	CbGbCtD
Progesterone—AR—Spironolactone—dilated cardiomyopathy	0.0305	0.153	CbGbCtD
Progesterone—Eplerenone—Spironolactone—dilated cardiomyopathy	0.0235	0.101	CrCrCtD
Progesterone—Oxandrolone—Spironolactone—dilated cardiomyopathy	0.0221	0.095	CrCrCtD
Progesterone—NR3C1—Spironolactone—dilated cardiomyopathy	0.0194	0.0973	CbGbCtD
Progesterone—Dydrogesterone—Spironolactone—dilated cardiomyopathy	0.0187	0.0805	CrCrCtD
Progesterone—Drospirenone—Spironolactone—dilated cardiomyopathy	0.0187	0.0805	CrCrCtD
Progesterone—Potassium Canrenoate—Spironolactone—dilated cardiomyopathy	0.0178	0.0767	CrCrCtD
Progesterone—Megestrol acetate—Spironolactone—dilated cardiomyopathy	0.0163	0.0702	CrCrCtD
Progesterone—Medroxyprogesterone Acetate—Spironolactone—dilated cardiomyopathy	0.0145	0.0624	CrCrCtD
Progesterone—Hydrocortamate—Spironolactone—dilated cardiomyopathy	0.0131	0.0563	CrCrCtD
Progesterone—Cortisone acetate—Spironolactone—dilated cardiomyopathy	0.0127	0.0546	CrCrCtD
Progesterone—Testolactone—Spironolactone—dilated cardiomyopathy	0.0123	0.053	CrCrCtD
Progesterone—Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.0113	0.0487	CrCrCtD
Progesterone—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.011	0.0474	CrCrCtD
Progesterone—Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.011	0.0474	CrCrCtD
Progesterone—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.0107	0.0462	CrCrCtD
Progesterone—Testosterone—Spironolactone—dilated cardiomyopathy	0.00956	0.0412	CrCrCtD
Progesterone—Hydrocortisone—Spironolactone—dilated cardiomyopathy	0.00898	0.0387	CrCrCtD
Progesterone—CYP2C8—Spironolactone—dilated cardiomyopathy	0.00667	0.0335	CbGbCtD
Progesterone—ABCB1—Lisinopril—dilated cardiomyopathy	0.00513	0.0257	CbGbCtD
Progesterone—ABCB1—Spironolactone—dilated cardiomyopathy	0.00452	0.0227	CbGbCtD
Progesterone—Carcinoma breast—Spironolactone—dilated cardiomyopathy	0.00295	0.0852	CcSEcCtD
Progesterone—Patent ductus arteriosus—Furosemide—dilated cardiomyopathy	0.0026	0.0753	CcSEcCtD
Progesterone—CYP2C9—cardial valve—dilated cardiomyopathy	0.0014	0.289	CbGeAlD
Progesterone—Breast cancer—Spironolactone—dilated cardiomyopathy	0.00109	0.0316	CcSEcCtD
Progesterone—Glucose tolerance decreased—Furosemide—dilated cardiomyopathy	0.00108	0.0313	CcSEcCtD
Progesterone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00072	0.0208	CcSEcCtD
Progesterone—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.000615	0.0178	CcSEcCtD
Progesterone—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.00047	0.0136	CcSEcCtD
Progesterone—Breast pain—Spironolactone—dilated cardiomyopathy	0.000457	0.0132	CcSEcCtD
Progesterone—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.000456	0.0132	CcSEcCtD
Progesterone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.000454	0.0131	CcSEcCtD
Progesterone—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.000369	0.0107	CcSEcCtD
Progesterone—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.000366	0.0106	CcSEcCtD
Progesterone—Leg pain—Lisinopril—dilated cardiomyopathy	0.000353	0.0102	CcSEcCtD
Progesterone—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.000322	0.00933	CcSEcCtD
Progesterone—Eplerenone—NR3C2—dilated cardiomyopathy	0.000317	0.242	CrCbGaD
Progesterone—Thrombosis—Furosemide—dilated cardiomyopathy	0.000306	0.00887	CcSEcCtD
Progesterone—Drospirenone—NR3C2—dilated cardiomyopathy	0.000304	0.232	CrCbGaD
Progesterone—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.000286	0.218	CrCbGaD
Progesterone—Cholestasis—Furosemide—dilated cardiomyopathy	0.000286	0.00827	CcSEcCtD
Progesterone—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000261	0.00754	CcSEcCtD
Progesterone—Gastritis—Spironolactone—dilated cardiomyopathy	0.000256	0.00741	CcSEcCtD
Progesterone—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00025	0.00725	CcSEcCtD
Progesterone—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000247	0.00714	CcSEcCtD
Progesterone—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.000237	0.00686	CcSEcCtD
Progesterone—Drug interaction—Furosemide—dilated cardiomyopathy	0.000234	0.00677	CcSEcCtD
Progesterone—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.000228	0.00659	CcSEcCtD
Progesterone—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000223	0.00645	CcSEcCtD
Progesterone—NR3C2—cardiac ventricle—dilated cardiomyopathy	0.000222	0.0457	CbGeAlD
Progesterone—Spironolactone—NR3C2—dilated cardiomyopathy	0.000216	0.165	CrCbGaD
Progesterone—NR3C2—myocardium—dilated cardiomyopathy	0.000209	0.043	CbGeAlD
Progesterone—Memory impairment—Lisinopril—dilated cardiomyopathy	0.000207	0.006	CcSEcCtD
Progesterone—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000199	0.00577	CcSEcCtD
Progesterone—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000196	0.00568	CcSEcCtD
Progesterone—Bladder pain—Furosemide—dilated cardiomyopathy	0.000196	0.00567	CcSEcCtD
Progesterone—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000194	0.00562	CcSEcCtD
Progesterone—PGR—myocardium—dilated cardiomyopathy	0.000194	0.04	CbGeAlD
Progesterone—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000189	0.00548	CcSEcCtD
Progesterone—Mental disability—Furosemide—dilated cardiomyopathy	0.000188	0.00545	CcSEcCtD
Progesterone—Prednisolone—NR3C2—dilated cardiomyopathy	0.000188	0.143	CrCbGaD
Progesterone—Breast pain—Lisinopril—dilated cardiomyopathy	0.000187	0.0054	CcSEcCtD
Progesterone—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000185	0.00536	CcSEcCtD
Progesterone—Accidental injury—Lisinopril—dilated cardiomyopathy	0.000184	0.00532	CcSEcCtD
Progesterone—SIGMAR1—cardiac ventricle—dilated cardiomyopathy	0.000182	0.0376	CbGeAlD
Progesterone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000182	0.00526	CcSEcCtD
Progesterone—Viral infection—Lisinopril—dilated cardiomyopathy	0.00018	0.00521	CcSEcCtD
Progesterone—Swelling—Furosemide—dilated cardiomyopathy	0.000178	0.00516	CcSEcCtD
Progesterone—Alopecia—Spironolactone—dilated cardiomyopathy	0.000177	0.00512	CcSEcCtD
Progesterone—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000176	0.00509	CcSEcCtD
Progesterone—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000175	0.00508	CcSEcCtD
Progesterone—SIGMAR1—myocardium—dilated cardiomyopathy	0.000172	0.0354	CbGeAlD
Progesterone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000168	0.00485	CcSEcCtD
Progesterone—Thirst—Furosemide—dilated cardiomyopathy	0.000165	0.00479	CcSEcCtD
Progesterone—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000165	0.00477	CcSEcCtD
Progesterone—AR—cardiac ventricle—dilated cardiomyopathy	0.000164	0.0339	CbGeAlD
Progesterone—Purpura—Furosemide—dilated cardiomyopathy	0.000163	0.00473	CcSEcCtD
Progesterone—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000163	0.00471	CcSEcCtD
Progesterone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000163	0.00471	CcSEcCtD
Progesterone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000162	0.00468	CcSEcCtD
Progesterone—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000159	0.0046	CcSEcCtD
Progesterone—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000158	0.00457	CcSEcCtD
Progesterone—Malaise—Spironolactone—dilated cardiomyopathy	0.000157	0.00455	CcSEcCtD
Progesterone—Cystitis—Lisinopril—dilated cardiomyopathy	0.000157	0.00455	CcSEcCtD
Progesterone—AR—myocardium—dilated cardiomyopathy	0.000155	0.0319	CbGeAlD
Progesterone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000155	0.00447	CcSEcCtD
Progesterone—Irritability—Furosemide—dilated cardiomyopathy	0.00015	0.00435	CcSEcCtD
Progesterone—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000147	0.00426	CcSEcCtD
Progesterone—ABCC1—myocardium—dilated cardiomyopathy	0.000147	0.0303	CbGeAlD
Progesterone—Discomfort—Spironolactone—dilated cardiomyopathy	0.000147	0.00424	CcSEcCtD
Progesterone—NR3C2—heart—dilated cardiomyopathy	0.000146	0.03	CbGeAlD
Progesterone—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000146	0.00421	CcSEcCtD
Progesterone—Confusional state—Spironolactone—dilated cardiomyopathy	0.000143	0.00415	CcSEcCtD
Progesterone—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000143	0.00413	CcSEcCtD
Progesterone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000142	0.00412	CcSEcCtD
Progesterone—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000142	0.0041	CcSEcCtD
Progesterone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000137	0.00396	CcSEcCtD
Progesterone—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000136	0.00395	CcSEcCtD
Progesterone—PGR—heart—dilated cardiomyopathy	0.000135	0.0279	CbGeAlD
Progesterone—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000135	0.00391	CcSEcCtD
Progesterone—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000133	0.00386	CcSEcCtD
Progesterone—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000131	0.0038	CcSEcCtD
Progesterone—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00013	0.00375	CcSEcCtD
Progesterone—Injury—Lisinopril—dilated cardiomyopathy	0.000129	0.00372	CcSEcCtD
Progesterone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000127	0.00369	CcSEcCtD
Progesterone—Somnolence—Spironolactone—dilated cardiomyopathy	0.000126	0.00366	CcSEcCtD
Progesterone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000126	0.00364	CcSEcCtD
Progesterone—NR3C2—cardiac atrium—dilated cardiomyopathy	0.000125	0.0257	CbGeAlD
Progesterone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000123	0.00355	CcSEcCtD
Progesterone—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000123	0.00355	CcSEcCtD
Progesterone—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.000123	0.0253	CbGeAlD
Progesterone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000122	0.00353	CcSEcCtD
Progesterone—Arthritis—Lisinopril—dilated cardiomyopathy	0.000122	0.00352	CcSEcCtD
Progesterone—Drowsiness—Furosemide—dilated cardiomyopathy	0.000121	0.00351	CcSEcCtD
Progesterone—SIGMAR1—heart—dilated cardiomyopathy	0.00012	0.0247	CbGeAlD
Progesterone—NR3C1—cardiac ventricle—dilated cardiomyopathy	0.000119	0.0245	CbGeAlD
Progesterone—Diplopia—Lisinopril—dilated cardiomyopathy	0.000118	0.00342	CcSEcCtD
Progesterone—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000118	0.00342	CcSEcCtD
Progesterone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000118	0.00342	CcSEcCtD
Progesterone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000117	0.00339	CcSEcCtD
Progesterone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000117	0.00339	CcSEcCtD
Progesterone—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000115	0.00332	CcSEcCtD
Progesterone—Face oedema—Lisinopril—dilated cardiomyopathy	0.000114	0.0033	CcSEcCtD
Progesterone—CYP1B1—heart—dilated cardiomyopathy	0.000114	0.0235	CbGeAlD
Progesterone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000113	0.00327	CcSEcCtD
Progesterone—Irritability—Lisinopril—dilated cardiomyopathy	0.000113	0.00326	CcSEcCtD
Progesterone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000112	0.00325	CcSEcCtD
Progesterone—NR3C1—myocardium—dilated cardiomyopathy	0.000112	0.0231	CbGeAlD
Progesterone—AR—heart—dilated cardiomyopathy	0.000108	0.0222	CbGeAlD
Progesterone—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000108	0.00311	CcSEcCtD
Progesterone—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000107	0.00309	CcSEcCtD
Progesterone—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000107	0.00309	CcSEcCtD
Progesterone—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000106	0.00308	CcSEcCtD
Progesterone—ESR1—heart—dilated cardiomyopathy	0.000106	0.0218	CbGeAlD
Progesterone—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000106	0.00306	CcSEcCtD
Progesterone—Visual impairment—Furosemide—dilated cardiomyopathy	0.000105	0.00304	CcSEcCtD
Progesterone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000105	0.00303	CcSEcCtD
Progesterone—Gastritis—Lisinopril—dilated cardiomyopathy	0.000105	0.00303	CcSEcCtD
Progesterone—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000103	0.00298	CcSEcCtD
Progesterone—SIGMAR1—cardiac atrium—dilated cardiomyopathy	0.000102	0.0211	CbGeAlD
Progesterone—ABCC1—heart—dilated cardiomyopathy	0.000102	0.0211	CbGeAlD
Progesterone—Asthma—Lisinopril—dilated cardiomyopathy	0.000102	0.00295	CcSEcCtD
Progesterone—Eye disorder—Furosemide—dilated cardiomyopathy	0.000102	0.00295	CcSEcCtD
Progesterone—Tinnitus—Furosemide—dilated cardiomyopathy	0.000102	0.00294	CcSEcCtD
Progesterone—Pruritus—Spironolactone—dilated cardiomyopathy	0.000101	0.00291	CcSEcCtD
Progesterone—Angina pectoris—Lisinopril—dilated cardiomyopathy	9.95e-05	0.00288	CcSEcCtD
Progesterone—Sweating increased—Lisinopril—dilated cardiomyopathy	9.95e-05	0.00288	CcSEcCtD
Progesterone—Angiopathy—Furosemide—dilated cardiomyopathy	9.88e-05	0.00286	CcSEcCtD
Progesterone—Immune system disorder—Furosemide—dilated cardiomyopathy	9.84e-05	0.00285	CcSEcCtD
Progesterone—Bronchitis—Lisinopril—dilated cardiomyopathy	9.82e-05	0.00284	CcSEcCtD
Progesterone—Diarrhoea—Spironolactone—dilated cardiomyopathy	9.73e-05	0.00282	CcSEcCtD
Progesterone—Dysuria—Lisinopril—dilated cardiomyopathy	9.55e-05	0.00276	CcSEcCtD
Progesterone—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	9.49e-05	0.00275	CcSEcCtD
Progesterone—Erythema—Furosemide—dilated cardiomyopathy	9.48e-05	0.00274	CcSEcCtD
Progesterone—Malnutrition—Furosemide—dilated cardiomyopathy	9.48e-05	0.00274	CcSEcCtD
Progesterone—Dizziness—Spironolactone—dilated cardiomyopathy	9.41e-05	0.00272	CcSEcCtD
Progesterone—Flatulence—Furosemide—dilated cardiomyopathy	9.34e-05	0.0027	CcSEcCtD
Progesterone—Weight increased—Lisinopril—dilated cardiomyopathy	9.29e-05	0.00269	CcSEcCtD
Progesterone—Weight decreased—Lisinopril—dilated cardiomyopathy	9.24e-05	0.00267	CcSEcCtD
Progesterone—AR—cardiac atrium—dilated cardiomyopathy	9.23e-05	0.019	CbGeAlD
Progesterone—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	9.21e-05	0.00267	CcSEcCtD
Progesterone—Pneumonia—Lisinopril—dilated cardiomyopathy	9.16e-05	0.00265	CcSEcCtD
Progesterone—Muscle spasms—Furosemide—dilated cardiomyopathy	9.12e-05	0.00264	CcSEcCtD
Progesterone—Depression—Lisinopril—dilated cardiomyopathy	9.08e-05	0.00263	CcSEcCtD
Progesterone—Vomiting—Spironolactone—dilated cardiomyopathy	9.04e-05	0.00262	CcSEcCtD
Progesterone—Rash—Spironolactone—dilated cardiomyopathy	8.97e-05	0.0026	CcSEcCtD
Progesterone—Dermatitis—Spironolactone—dilated cardiomyopathy	8.96e-05	0.00259	CcSEcCtD
Progesterone—Vision blurred—Furosemide—dilated cardiomyopathy	8.94e-05	0.00259	CcSEcCtD
Progesterone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	8.92e-05	0.00258	CcSEcCtD
Progesterone—Headache—Spironolactone—dilated cardiomyopathy	8.91e-05	0.00258	CcSEcCtD
Progesterone—Jaundice—Lisinopril—dilated cardiomyopathy	8.87e-05	0.00257	CcSEcCtD
Progesterone—Urinary tract infection—Lisinopril—dilated cardiomyopathy	8.85e-05	0.00256	CcSEcCtD
Progesterone—Anaemia—Furosemide—dilated cardiomyopathy	8.76e-05	0.00254	CcSEcCtD
Progesterone—ABCC1—cardiac atrium—dilated cardiomyopathy	8.76e-05	0.0181	CbGeAlD
Progesterone—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	8.61e-05	0.00249	CcSEcCtD
Progesterone—Sinusitis—Lisinopril—dilated cardiomyopathy	8.54e-05	0.00247	CcSEcCtD
Progesterone—Vertigo—Furosemide—dilated cardiomyopathy	8.52e-05	0.00247	CcSEcCtD
Progesterone—Nausea—Spironolactone—dilated cardiomyopathy	8.45e-05	0.00244	CcSEcCtD
Progesterone—Rhinitis—Lisinopril—dilated cardiomyopathy	8.19e-05	0.00237	CcSEcCtD
Progesterone—Hepatitis—Lisinopril—dilated cardiomyopathy	8.17e-05	0.00237	CcSEcCtD
Progesterone—Pharyngitis—Lisinopril—dilated cardiomyopathy	8.11e-05	0.00235	CcSEcCtD
Progesterone—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	8.07e-05	0.00234	CcSEcCtD
Progesterone—CYP1A1—heart—dilated cardiomyopathy	8.05e-05	0.0166	CbGeAlD
Progesterone—Oedema peripheral—Lisinopril—dilated cardiomyopathy	8.05e-05	0.00233	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	8.02e-05	0.00232	CcSEcCtD
Progesterone—Urethral disorder—Lisinopril—dilated cardiomyopathy	8.01e-05	0.00232	CcSEcCtD
Progesterone—Dry mouth—Furosemide—dilated cardiomyopathy	7.9e-05	0.00228	CcSEcCtD
Progesterone—NR3C1—heart—dilated cardiomyopathy	7.81e-05	0.0161	CbGeAlD
Progesterone—Confusional state—Furosemide—dilated cardiomyopathy	7.8e-05	0.00226	CcSEcCtD
Progesterone—CYP2C9—heart—dilated cardiomyopathy	7.75e-05	0.016	CbGeAlD
Progesterone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	7.74e-05	0.00224	CcSEcCtD
Progesterone—Erythema multiforme—Lisinopril—dilated cardiomyopathy	7.73e-05	0.00224	CcSEcCtD
Progesterone—Tinnitus—Lisinopril—dilated cardiomyopathy	7.62e-05	0.00221	CcSEcCtD
Progesterone—Shock—Furosemide—dilated cardiomyopathy	7.61e-05	0.0022	CcSEcCtD
Progesterone—Nervous system disorder—Furosemide—dilated cardiomyopathy	7.59e-05	0.0022	CcSEcCtD
Progesterone—Skin disorder—Furosemide—dilated cardiomyopathy	7.52e-05	0.00218	CcSEcCtD
Progesterone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	7.48e-05	0.00216	CcSEcCtD
Progesterone—Angiopathy—Lisinopril—dilated cardiomyopathy	7.42e-05	0.00215	CcSEcCtD
Progesterone—Anorexia—Furosemide—dilated cardiomyopathy	7.38e-05	0.00213	CcSEcCtD
Progesterone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	7.37e-05	0.00213	CcSEcCtD
Progesterone—Hypotension—Furosemide—dilated cardiomyopathy	7.23e-05	0.00209	CcSEcCtD
Progesterone—Alopecia—Lisinopril—dilated cardiomyopathy	7.22e-05	0.00209	CcSEcCtD
Progesterone—Mental disorder—Lisinopril—dilated cardiomyopathy	7.16e-05	0.00207	CcSEcCtD
Progesterone—Malnutrition—Lisinopril—dilated cardiomyopathy	7.11e-05	0.00206	CcSEcCtD
Progesterone—Erythema—Lisinopril—dilated cardiomyopathy	7.11e-05	0.00206	CcSEcCtD
Progesterone—Flatulence—Lisinopril—dilated cardiomyopathy	7.01e-05	0.00203	CcSEcCtD
Progesterone—Tension—Lisinopril—dilated cardiomyopathy	6.98e-05	0.00202	CcSEcCtD
Progesterone—Paraesthesia—Furosemide—dilated cardiomyopathy	6.95e-05	0.00201	CcSEcCtD
Progesterone—Nervousness—Lisinopril—dilated cardiomyopathy	6.91e-05	0.002	CcSEcCtD
Progesterone—CYP1A1—cardiac atrium—dilated cardiomyopathy	6.89e-05	0.0142	CbGeAlD
Progesterone—Back pain—Lisinopril—dilated cardiomyopathy	6.88e-05	0.00199	CcSEcCtD
Progesterone—Somnolence—Furosemide—dilated cardiomyopathy	6.88e-05	0.00199	CcSEcCtD
Progesterone—Muscle spasms—Lisinopril—dilated cardiomyopathy	6.84e-05	0.00198	CcSEcCtD
Progesterone—Decreased appetite—Furosemide—dilated cardiomyopathy	6.73e-05	0.00195	CcSEcCtD
Progesterone—Vision blurred—Lisinopril—dilated cardiomyopathy	6.71e-05	0.00194	CcSEcCtD
Progesterone—NR3C1—cardiac atrium—dilated cardiomyopathy	6.68e-05	0.0138	CbGeAlD
Progesterone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	6.68e-05	0.00193	CcSEcCtD
Progesterone—Fatigue—Furosemide—dilated cardiomyopathy	6.67e-05	0.00193	CcSEcCtD
Progesterone—Tremor—Lisinopril—dilated cardiomyopathy	6.67e-05	0.00193	CcSEcCtD
Progesterone—Pain—Furosemide—dilated cardiomyopathy	6.62e-05	0.00191	CcSEcCtD
Progesterone—Constipation—Furosemide—dilated cardiomyopathy	6.62e-05	0.00191	CcSEcCtD
Progesterone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	6.6e-05	0.00191	CcSEcCtD
Progesterone—Anaemia—Lisinopril—dilated cardiomyopathy	6.58e-05	0.0019	CcSEcCtD
Progesterone—Angioedema—Lisinopril—dilated cardiomyopathy	6.5e-05	0.00188	CcSEcCtD
Progesterone—Malaise—Lisinopril—dilated cardiomyopathy	6.42e-05	0.00186	CcSEcCtD
Progesterone—Vertigo—Lisinopril—dilated cardiomyopathy	6.39e-05	0.00185	CcSEcCtD
Progesterone—Syncope—Lisinopril—dilated cardiomyopathy	6.38e-05	0.00185	CcSEcCtD
Progesterone—Feeling abnormal—Furosemide—dilated cardiomyopathy	6.38e-05	0.00185	CcSEcCtD
Progesterone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	6.33e-05	0.00183	CcSEcCtD
Progesterone—Palpitations—Lisinopril—dilated cardiomyopathy	6.29e-05	0.00182	CcSEcCtD
Progesterone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	6.25e-05	0.00181	CcSEcCtD
Progesterone—Cough—Lisinopril—dilated cardiomyopathy	6.21e-05	0.0018	CcSEcCtD
Progesterone—Urticaria—Furosemide—dilated cardiomyopathy	6.15e-05	0.00178	CcSEcCtD
Progesterone—Abdominal pain—Furosemide—dilated cardiomyopathy	6.12e-05	0.00177	CcSEcCtD
Progesterone—Body temperature increased—Furosemide—dilated cardiomyopathy	6.12e-05	0.00177	CcSEcCtD
Progesterone—Myalgia—Lisinopril—dilated cardiomyopathy	6.06e-05	0.00175	CcSEcCtD
Progesterone—Chest pain—Lisinopril—dilated cardiomyopathy	6.06e-05	0.00175	CcSEcCtD
Progesterone—Arthralgia—Lisinopril—dilated cardiomyopathy	6.06e-05	0.00175	CcSEcCtD
Progesterone—Anxiety—Lisinopril—dilated cardiomyopathy	6.04e-05	0.00175	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	6.02e-05	0.00174	CcSEcCtD
Progesterone—Discomfort—Lisinopril—dilated cardiomyopathy	5.98e-05	0.00173	CcSEcCtD
Progesterone—Dry mouth—Lisinopril—dilated cardiomyopathy	5.92e-05	0.00171	CcSEcCtD
Progesterone—Confusional state—Lisinopril—dilated cardiomyopathy	5.85e-05	0.00169	CcSEcCtD
Progesterone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	5.81e-05	0.00168	CcSEcCtD
Progesterone—Oedema—Lisinopril—dilated cardiomyopathy	5.81e-05	0.00168	CcSEcCtD
Progesterone—Infection—Lisinopril—dilated cardiomyopathy	5.77e-05	0.00167	CcSEcCtD
Progesterone—Shock—Lisinopril—dilated cardiomyopathy	5.71e-05	0.00165	CcSEcCtD
Progesterone—Hypersensitivity—Furosemide—dilated cardiomyopathy	5.7e-05	0.00165	CcSEcCtD
Progesterone—Tachycardia—Lisinopril—dilated cardiomyopathy	5.67e-05	0.00164	CcSEcCtD
Progesterone—Skin disorder—Lisinopril—dilated cardiomyopathy	5.64e-05	0.00163	CcSEcCtD
Progesterone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	5.61e-05	0.00162	CcSEcCtD
Progesterone—Asthenia—Furosemide—dilated cardiomyopathy	5.55e-05	0.00161	CcSEcCtD
Progesterone—Anorexia—Lisinopril—dilated cardiomyopathy	5.53e-05	0.0016	CcSEcCtD
Progesterone—Pruritus—Furosemide—dilated cardiomyopathy	5.48e-05	0.00158	CcSEcCtD
Progesterone—Hypotension—Lisinopril—dilated cardiomyopathy	5.43e-05	0.00157	CcSEcCtD
Progesterone—Diarrhoea—Furosemide—dilated cardiomyopathy	5.3e-05	0.00153	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	5.29e-05	0.00153	CcSEcCtD
Progesterone—Insomnia—Lisinopril—dilated cardiomyopathy	5.25e-05	0.00152	CcSEcCtD
Progesterone—Paraesthesia—Lisinopril—dilated cardiomyopathy	5.21e-05	0.00151	CcSEcCtD
Progesterone—Dyspnoea—Lisinopril—dilated cardiomyopathy	5.18e-05	0.0015	CcSEcCtD
Progesterone—Somnolence—Lisinopril—dilated cardiomyopathy	5.16e-05	0.00149	CcSEcCtD
Progesterone—Dizziness—Furosemide—dilated cardiomyopathy	5.12e-05	0.00148	CcSEcCtD
Progesterone—Dyspepsia—Lisinopril—dilated cardiomyopathy	5.11e-05	0.00148	CcSEcCtD
Progesterone—Decreased appetite—Lisinopril—dilated cardiomyopathy	5.05e-05	0.00146	CcSEcCtD
Progesterone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	5.01e-05	0.00145	CcSEcCtD
Progesterone—Fatigue—Lisinopril—dilated cardiomyopathy	5.01e-05	0.00145	CcSEcCtD
Progesterone—Pain—Lisinopril—dilated cardiomyopathy	4.97e-05	0.00144	CcSEcCtD
Progesterone—Constipation—Lisinopril—dilated cardiomyopathy	4.97e-05	0.00144	CcSEcCtD
Progesterone—Vomiting—Furosemide—dilated cardiomyopathy	4.92e-05	0.00142	CcSEcCtD
Progesterone—Rash—Furosemide—dilated cardiomyopathy	4.88e-05	0.00141	CcSEcCtD
Progesterone—Dermatitis—Furosemide—dilated cardiomyopathy	4.87e-05	0.00141	CcSEcCtD
Progesterone—Headache—Furosemide—dilated cardiomyopathy	4.85e-05	0.0014	CcSEcCtD
Progesterone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	4.78e-05	0.00138	CcSEcCtD
Progesterone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	4.75e-05	0.00137	CcSEcCtD
Progesterone—Urticaria—Lisinopril—dilated cardiomyopathy	4.61e-05	0.00133	CcSEcCtD
Progesterone—Nausea—Furosemide—dilated cardiomyopathy	4.6e-05	0.00133	CcSEcCtD
Progesterone—Abdominal pain—Lisinopril—dilated cardiomyopathy	4.59e-05	0.00133	CcSEcCtD
Progesterone—Body temperature increased—Lisinopril—dilated cardiomyopathy	4.59e-05	0.00133	CcSEcCtD
Progesterone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	4.28e-05	0.00124	CcSEcCtD
Progesterone—ABCB1—heart—dilated cardiomyopathy	4.18e-05	0.00862	CbGeAlD
Progesterone—Asthenia—Lisinopril—dilated cardiomyopathy	4.17e-05	0.00121	CcSEcCtD
Progesterone—Pruritus—Lisinopril—dilated cardiomyopathy	4.11e-05	0.00119	CcSEcCtD
Progesterone—Diarrhoea—Lisinopril—dilated cardiomyopathy	3.97e-05	0.00115	CcSEcCtD
Progesterone—Dizziness—Lisinopril—dilated cardiomyopathy	3.84e-05	0.00111	CcSEcCtD
Progesterone—Vomiting—Lisinopril—dilated cardiomyopathy	3.69e-05	0.00107	CcSEcCtD
Progesterone—Rash—Lisinopril—dilated cardiomyopathy	3.66e-05	0.00106	CcSEcCtD
Progesterone—Dermatitis—Lisinopril—dilated cardiomyopathy	3.66e-05	0.00106	CcSEcCtD
Progesterone—Headache—Lisinopril—dilated cardiomyopathy	3.64e-05	0.00105	CcSEcCtD
Progesterone—Nausea—Lisinopril—dilated cardiomyopathy	3.45e-05	0.000998	CcSEcCtD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.37e-05	0.000882	CbGpPWpGaD
Progesterone—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	1.35e-05	0.000868	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	1.34e-05	0.00086	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.34e-05	0.000859	CbGpPWpGaD
Progesterone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	1.32e-05	0.000849	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	1.29e-05	0.000832	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	1.29e-05	0.00083	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	1.29e-05	0.00083	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—EGFR—dilated cardiomyopathy	1.28e-05	0.00082	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	1.27e-05	0.00082	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	1.26e-05	0.000809	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.26e-05	0.000807	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	1.23e-05	0.00079	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	1.23e-05	0.00079	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	1.22e-05	0.000782	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	1.21e-05	0.000778	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	1.2e-05	0.000771	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.18e-05	0.000759	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	1.18e-05	0.000757	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	1.17e-05	0.00075	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.17e-05	0.000749	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.15e-05	0.00074	CbGpPWpGaD
Progesterone—PGR—Gene Expression—NPPA—dilated cardiomyopathy	1.15e-05	0.000738	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.14e-05	0.000734	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	1.14e-05	0.000732	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.12e-05	0.00072	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	1.1e-05	0.000708	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	1.1e-05	0.000706	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	1.1e-05	0.000704	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	1.09e-05	0.000702	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	1.09e-05	0.000698	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.07e-05	0.00069	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	1.07e-05	0.00069	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	1.07e-05	0.000688	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	1.06e-05	0.000679	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	1.02e-05	0.000657	CbGpPWpGaD
Progesterone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	1.01e-05	0.00065	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.01e-05	0.000649	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	1.01e-05	0.000647	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	9.92e-06	0.000638	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	9.91e-06	0.000637	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	9.77e-06	0.000628	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.68e-06	0.000623	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.42e-06	0.000606	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.42e-06	0.000606	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.37e-06	0.000602	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.37e-06	0.000602	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.24e-06	0.000594	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	9.23e-06	0.000594	CbGpPWpGaD
Progesterone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	9.1e-06	0.000585	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	9.09e-06	0.000585	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	9.09e-06	0.000585	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	9.06e-06	0.000583	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9e-06	0.000578	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	8.97e-06	0.000577	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.76e-06	0.000563	CbGpPWpGaD
Progesterone—AR—Gene Expression—NPPA—dilated cardiomyopathy	8.74e-06	0.000562	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.71e-06	0.00056	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.51e-06	0.000547	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.51e-06	0.000547	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	8.49e-06	0.000546	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	8.43e-06	0.000542	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.43e-06	0.000542	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	8.23e-06	0.000529	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	8.23e-06	0.000529	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.1e-06	0.000521	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.09e-06	0.000521	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	7.97e-06	0.000512	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	7.96e-06	0.000512	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	7.93e-06	0.00051	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.91e-06	0.000509	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.91e-06	0.000508	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	7.83e-06	0.000504	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	7.83e-06	0.000504	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.71e-06	0.000496	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	7.67e-06	0.000494	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.66e-06	0.000492	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	7.52e-06	0.000484	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	7.49e-06	0.000482	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	7.49e-06	0.000481	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	7.4e-06	0.000476	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	7.31e-06	0.00047	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	7.26e-06	0.000467	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.23e-06	0.000465	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.2e-06	0.000463	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	7.17e-06	0.000461	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—GPX1—dilated cardiomyopathy	6.98e-06	0.000449	CbGpPWpGaD
Progesterone—ABCC1—Disease—NPPA—dilated cardiomyopathy	6.95e-06	0.000447	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.94e-06	0.000446	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.88e-06	0.000442	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	6.87e-06	0.000442	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.83e-06	0.000439	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—CD36—dilated cardiomyopathy	6.8e-06	0.000437	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	6.78e-06	0.000436	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.76e-06	0.000435	CbGpPWpGaD
Progesterone—ABCC1—Disease—PSEN2—dilated cardiomyopathy	6.73e-06	0.000433	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	6.73e-06	0.000433	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.71e-06	0.000432	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	6.63e-06	0.000426	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.54e-06	0.000421	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.54e-06	0.00042	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	6.52e-06	0.000419	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	6.5e-06	0.000418	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.42e-06	0.000413	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.42e-06	0.000413	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	6.37e-06	0.000409	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	6.36e-06	0.000409	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.24e-06	0.000401	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	6.21e-06	0.000399	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.2e-06	0.000399	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	6.13e-06	0.000394	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—AGT—dilated cardiomyopathy	6.12e-06	0.000394	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.08e-06	0.000391	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	6.06e-06	0.00039	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	6e-06	0.000386	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	5.98e-06	0.000385	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.96e-06	0.000384	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	5.95e-06	0.000382	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.94e-06	0.000382	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.88e-06	0.000378	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.78e-06	0.000371	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.66e-06	0.000364	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	5.64e-06	0.000363	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	5.59e-06	0.00036	CbGpPWpGaD
Progesterone—SLC22A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.57e-06	0.000358	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	5.54e-06	0.000357	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	5.41e-06	0.000348	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.3e-06	0.000341	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—GPX1—dilated cardiomyopathy	5.12e-06	0.000329	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	5.1e-06	0.000328	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	5.08e-06	0.000327	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.07e-06	0.000326	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	5.06e-06	0.000325	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.02e-06	0.000323	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.02e-06	0.000323	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—CD36—dilated cardiomyopathy	4.99e-06	0.000321	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.93e-06	0.000317	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.82e-06	0.00031	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.81e-06	0.000309	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	4.78e-06	0.000307	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.68e-06	0.000301	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.67e-06	0.0003	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.6e-06	0.000296	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.52e-06	0.000291	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AGT—dilated cardiomyopathy	4.49e-06	0.000289	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	4.32e-06	0.000278	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—GPX1—dilated cardiomyopathy	4.29e-06	0.000276	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.24e-06	0.000273	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CD36—dilated cardiomyopathy	4.18e-06	0.000269	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.13e-06	0.000266	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—GPX1—dilated cardiomyopathy	4.11e-06	0.000265	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.03e-06	0.000259	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.02e-06	0.000259	CbGpPWpGaD
Progesterone—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.02e-06	0.000258	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CD36—dilated cardiomyopathy	4.01e-06	0.000258	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.92e-06	0.000252	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.86e-06	0.000248	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.79e-06	0.000244	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.77e-06	0.000242	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.77e-06	0.000242	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	3.76e-06	0.000242	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.69e-06	0.000237	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.69e-06	0.000237	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.67e-06	0.000236	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—RAC1—dilated cardiomyopathy	3.63e-06	0.000234	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.62e-06	0.000233	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AGT—dilated cardiomyopathy	3.61e-06	0.000232	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.5e-06	0.000225	CbGpPWpGaD
Progesterone—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.5e-06	0.000225	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AGT—dilated cardiomyopathy	3.47e-06	0.000223	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.39e-06	0.000218	CbGpPWpGaD
Progesterone—ABCC1—Disease—RAC1—dilated cardiomyopathy	3.39e-06	0.000218	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.38e-06	0.000217	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.33e-06	0.000214	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.32e-06	0.000214	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.3e-06	0.000212	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.29e-06	0.000212	CbGpPWpGaD
Progesterone—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.26e-06	0.00021	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.19e-06	0.000205	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.15e-06	0.000203	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.14e-06	0.000202	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	3.09e-06	0.000199	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.08e-06	0.000198	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CD36—dilated cardiomyopathy	3.01e-06	0.000194	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3e-06	0.000193	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	2.99e-06	0.000192	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.97e-06	0.000191	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	2.91e-06	0.000187	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.9e-06	0.000186	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.85e-06	0.000183	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.75e-06	0.000177	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	2.72e-06	0.000175	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AGT—dilated cardiomyopathy	2.71e-06	0.000174	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.7e-06	0.000174	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	2.7e-06	0.000173	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	2.69e-06	0.000173	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.64e-06	0.000169	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	2.62e-06	0.000169	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	2.62e-06	0.000169	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	2.62e-06	0.000169	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.57e-06	0.000165	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	2.51e-06	0.000161	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	2.47e-06	0.000159	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	2.44e-06	0.000157	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—RAF1—dilated cardiomyopathy	2.41e-06	0.000155	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	2.41e-06	0.000155	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	2.36e-06	0.000152	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.36e-06	0.000152	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	2.36e-06	0.000152	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.31e-06	0.000149	CbGpPWpGaD
Progesterone—ABCC1—Disease—RAF1—dilated cardiomyopathy	2.25e-06	0.000144	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	2.2e-06	0.000141	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.19e-06	0.000141	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	2.17e-06	0.000139	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.13e-06	0.000137	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	2.04e-06	0.000131	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.95e-06	0.000125	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.91e-06	0.000123	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.9e-06	0.000122	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.89e-06	0.000121	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	1.84e-06	0.000118	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	1.79e-06	0.000115	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.71e-06	0.00011	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.69e-06	0.000109	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—dilated cardiomyopathy	1.65e-06	0.000106	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.64e-06	0.000106	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	1.61e-06	0.000104	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—dilated cardiomyopathy	1.54e-06	9.9e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.51e-06	9.69e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.48e-06	9.52e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.47e-06	9.45e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.47e-06	9.43e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.43e-06	9.21e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.41e-06	9.09e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.39e-06	8.91e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.37e-06	8.83e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.35e-06	8.68e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.34e-06	8.6e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.32e-06	8.49e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.29e-06	8.32e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.29e-06	8.29e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.21e-06	7.81e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.2e-06	7.74e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.17e-06	7.55e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.14e-06	7.35e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.03e-06	6.62e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.7e-07	6.24e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	9.06e-07	5.82e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	8.82e-07	5.67e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	7.94e-07	5.11e-05	CbGpPWpGaD
